arrow
M

Martin Bornhäuser

university hospital carl gustav carus
H指数:96
被引数:3.9万
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Deep learning predicts IDH1 mutation status in acute myeloid leukemia from bone marrow smears

深度学习预测骨髓涂片中的急性髓系白血病IDH1突变状态

2026-10-290
OAAI
Model-based integration of chimeric antigen receptor T-cell kinetics and tumor features to predict therapeutic outcomes in patients with B-cell malignancies

基于嵌合抗原受体T细胞动力学和肿瘤特征的模型整合,用于预测B细胞恶性肿瘤患者的治疗效果

2026-10-030
OAAI
Correction: Balaian et al. Systemic Metabolic Changes in Plasma of Patients with Myelodysplastic Neoplasms and Chronic Myelomonocytic Leukemia. Metabolites 2026, 16, 648

更正:Balaian等人。髓系发育不良肿瘤和慢性髓系单核细胞白血病患者血浆中的系统性代谢变化。Metabolites 2026, 16, 648

2026-09-300
OA
The SPIZ study: rationale and protocol of a randomized controlled trial to optimize interdisciplinary care of patients following cellular therapy through a digitally supported, cross-regional and cross-sectoral care model

SPIZ研究:一项随机对照试验的合理性与方案,旨在通过数字化支持、跨区域和跨部门护理模式优化细胞疗法后患者的多学科护理

2026-09-260
OAAI
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study

吉列替尼与异基因造血干细胞移植序贯治疗复发/难治FMS样酪氨酸激酶3(FLT3)突变急性髓系白血病患者的多中心真实世界研究

2026-09-050
OAAI
A pancreatic cancer organoid-macrophage co-culture using starPEG-heparin hydrogel deciphers tumor-immune cell interactions

使用星状PEG-肝素水凝胶的胰腺癌类器官-巨噬细胞共培养解析肿瘤-免疫细胞相互作用

2026-09-050
OA
Functional characterization of snoRNA-derived RNA (sdRNA) expression in healthy hematopoiesis and acute myeloid leukemia

在健康造血和急性髓系白血病中snoRNA衍生RNA(sdRNA)表达的分子功能鉴定

Leukemia
IF13.4
2026-09-040
OA
Gp120-Activated Allogeneic Regulatory T cells for Prevention of Graft-versus-Host-Disease – a First-in-Human Trial

Gp120激活的同种异基因调节性T细胞预防移植物抗宿主病——一项首次人体试验

2026-08-310
OAAI
PRDM16 expression is an independent prognostic factor in AML with the double-mutant NPM1/FLT3-ITD genotype

PRDM16表达是双突变NPM1/FLT3-ITD基因型AML的独立预后因素

2026-01-220
OAAI
Randomized Comparison of Cardiotoxicity With 60 Versus 90 mg Daunorubicin in AML Induction Therapy
2026-01-010
OAAI
Image-based explainable artificial intelligence accurately identifies myelodysplastic neoplasms beyond conventional signs of dysplasia

基于图像的可解释人工智能能够准确识别髓系发育不良性肿瘤,超出常规发育不良迹象的范畴。

2025-12-110
OAAI
Reduced intensity conditioning with 8 Gy total body irradiation in adult patients with acute lymphoblastic leukemia

减低强度预处理联合8 Gy全身照射在成人急性淋巴细胞白血病患者中的应用

2025-12-060
OAAI
MCL1 modulates mTORC1 signaling to promote bioenergetics and tumorigenesis

MCL1调节mTORC1信号通路以促进生物能量代谢和肿瘤发生。

2025-12-010
OA
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients

4978例接受强化治疗的AML欧洲患者队列中,髓系发育异常相关基因突变的不同预后影响

Leukemia
IF13.4
2025-10-270
OA